OncBioMune Pharmaceuticals, Inc Note Agreements

27 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Theralink Technologies, Inc. 2023 Convertible Secured Promissory Note with IMAC Holdings, Inc.
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2023
Promissory Note Amendment between Quint Media Inc. and Trels Investments, Ltd. (August 31, 2013)
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
2013
Promissory Note Amendment between PediatRx Inc. and Trels Investments, Ltd. (July 25, 2012)
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
2012
Promissory Note Amendment between PediatRx Inc. and Trels Investments, Ltd. (July 25, 2012)
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
2012
Promissory Note Amendment between PediatRx, Inc. and Trels Investments, Ltd. (April 19, 2011)
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
2012
Promissory Note Amendment between PediatRx, Inc. and Trels Investments, Ltd. (April 19, 2011)
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
2012
Promissory Note Amendment between PediatRx, Inc. and Benjamin Company S.A. dated May 23, 2011
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
2011
Promissory Note between Striker Energy Corp. and Benjamin Company S.A. dated September 16, 2010
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
2010
Promissory Note between Striker Energy Corp. and Benjamin Company S.A. dated July 26, 2010
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
2010
Promissory Note between Striker Energy Corp. and Trels Investments Ltd. dated June 15, 2009
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
2009
Demand Promissory Note between Theralink Technologies, Inc. and Lender
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
CO
2022
Theralink Technologies, Inc. 2022 Convertible Promissory Note Agreement
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2022
Theralink Technologies, Inc. 2021 Convertible Promissory Note Agreement with Holder
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2021
Theralink Technologies, Inc. 2021 Convertible Secured Promissory Note with Ashton Capital Corporation
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2021
OncBioMune Pharmaceuticals, Inc. 10% Senior Convertible Note Due May 25, 2020 (JEB Partners, L.P.)
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2019
OncBioMune Pharmaceuticals, Inc. 10% Senior Convertible Note Due February 3, 2020
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2019
OncBioMune Pharmaceuticals, Inc. 5% Senior Convertible Note Due February 26, 2020
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2019
OncBioMune Pharmaceuticals, Inc. 10% Senior Convertible Note Due November 25, 2019
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2019
10% Senior Convertible Note Agreement between OncBioMune Pharmaceuticals, Inc. and Cavalry Fund I LP (March 25, 2019)
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2019
5% Convertible Redeemable Note between OncBioMune Pharmaceuticals, Inc. and Cerberus Finance Group Ltd. (Due January 18, 2020)
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2019
5% Convertible Redeemable Note between OncBioMune Pharmaceuticals, Inc. and LG Capital Funding, LLC (Due January 18, 2020)
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2019
5% Senior Convertible Note Agreement between OncBioMune Pharmaceuticals, Inc. and Cavalry Fund I LP (November 13, 2018)
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2018
10% Original Issue Discount 5% Senior Convertible Note Due May 24, 2019 between OncBioMune Pharmaceuticals, Inc. and Cavalry Fund I LP
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2018
OncBioMune Pharmaceuticals, Inc. 8% Convertible Redeemable Note Due July 2019
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2018
OncBioMune Pharmaceuticals, Inc. 10% Senior Convertible Note Due November 13, 2018
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2018
OncBioMune Pharmaceuticals, Inc. 5% Senior Convertible Note Due September 29, 2018
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2018
OncBioMune, Inc. 10% Senior Convertible Note Due July 18, 2017
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2016